Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bekim Sadikovic

Showing results (91-100 of 231) with videos related to

Pageof 24
Sort By:
NPJ Genomic Medicine|July 20, 2021
Incidental findings from cancer next generation sequencing panelsNika Maani, Karen Panabaker, Jeanna M McCuaig, et al.
Frontiers in Genetics|June 8, 2026
Episignature leads to diagnosis and reclassification of DYRK1A variant in a child with syndromic neurodevelopmental disorder: a case reportInas Al-Younis, Laurence Basque, Nicolas Crapoulet, et al.
Human Molecular Genetics|October 10, 2013
NLRP7 affects trophoblast lineage differentiation, binds to overexpressed YY1 and alters CpG methylationSangeetha Mahadevan, Shu Wen, Ying-Wooi Wan, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Mutational Landscape of Patients Referred for Elevated Hemoglobin LevelPratibha Bhai, Benjamin Chin-Yee, Victor Pope, et al.
Frontiers in Oncology|July 24, 2023
Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratoryPratibha Bhai, Jacob Turowec, Stephanie Santos, et al.
Genes|July 27, 2024
De Novo Pathogenic Variant in <i>FBRSL1</i>, Non OMIM Gene Paralogue <i>AUTS2</i>, Causes a Novel Recognizable Syndromic Manifestation with Intellectual Disability; An Additional Patient and Review of the LiteratureNenad Bukvic, Marta De Rinaldis, Massimiliano Chetta, et al.
CMAJ Open|November 8, 2022
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart reviewBenjamin Chin-Yee, Maxim Matyashin, Ian Cheong, et al.
Genes|January 21, 2023
What Have We Learned from Patients Who Have Arboleda-Tham Syndrome Due to a De Novo <i>KAT6A</i> Pathogenic Variant with Impaired Histone Acetyltransferase Function? A Precise Clinical Description May Be Critical for Genetic Testing Approach and Final DiagnosisNenad Bukvic, Massimiliano Chetta, Rosanna Bagnulo, et al.
Frontiers in Genetics|July 30, 2021
Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based ApproachPratibha Bhai, Michael A Levy, Kathleen Rooney, et al.
Genes|August 28, 2025
Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson-Forssman-Lehmann (BFLS) and White-Kernohan (WHIKERS) SyndromesKeri Ramsey, Supraja Prakash, Jennifer Kerkhof, et al.
Pageof 24

Showing results (91-100 of 231) with videos related to

Sort By:
Pageof 24
NPJ Genomic Medicine|July 20, 2021
Incidental findings from cancer next generation sequencing panelsNika Maani, Karen Panabaker, Jeanna M McCuaig, et al.
Frontiers in Genetics|June 8, 2026
Episignature leads to diagnosis and reclassification of DYRK1A variant in a child with syndromic neurodevelopmental disorder: a case reportInas Al-Younis, Laurence Basque, Nicolas Crapoulet, et al.
Human Molecular Genetics|October 10, 2013
NLRP7 affects trophoblast lineage differentiation, binds to overexpressed YY1 and alters CpG methylationSangeetha Mahadevan, Shu Wen, Ying-Wooi Wan, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Mutational Landscape of Patients Referred for Elevated Hemoglobin LevelPratibha Bhai, Benjamin Chin-Yee, Victor Pope, et al.
Frontiers in Oncology|July 24, 2023
Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratoryPratibha Bhai, Jacob Turowec, Stephanie Santos, et al.
Genes|July 27, 2024
De Novo Pathogenic Variant in <i>FBRSL1</i>, Non OMIM Gene Paralogue <i>AUTS2</i>, Causes a Novel Recognizable Syndromic Manifestation with Intellectual Disability; An Additional Patient and Review of the LiteratureNenad Bukvic, Marta De Rinaldis, Massimiliano Chetta, et al.
CMAJ Open|November 8, 2022
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart reviewBenjamin Chin-Yee, Maxim Matyashin, Ian Cheong, et al.
Genes|January 21, 2023
What Have We Learned from Patients Who Have Arboleda-Tham Syndrome Due to a De Novo <i>KAT6A</i> Pathogenic Variant with Impaired Histone Acetyltransferase Function? A Precise Clinical Description May Be Critical for Genetic Testing Approach and Final DiagnosisNenad Bukvic, Massimiliano Chetta, Rosanna Bagnulo, et al.
Frontiers in Genetics|July 30, 2021
Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based ApproachPratibha Bhai, Michael A Levy, Kathleen Rooney, et al.
Genes|August 28, 2025
Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson-Forssman-Lehmann (BFLS) and White-Kernohan (WHIKERS) SyndromesKeri Ramsey, Supraja Prakash, Jennifer Kerkhof, et al.
Pageof 24